Enterprise Dose Monitoring

The Defense Health Agency (DHA) Medical Research and Development Contracting Division 2 is issuing a Sources‑Sought RFI to determine whether qualified Small Business firms can provide an Enterprise Dose Monitoring system that supports DHA patient‑safety, clinical decision‑making, and mission readiness. Respondents must submit a capability statement that addresses the seven task areas identified in Attachment 1: system architecture and availability; workstation, PACS, and OS integration; enterprise workload, templates, and reporting; hardware and peripheral requirements; clinical workflow and critical results; DoW system integration; and DoW cybersecurity/RMF compliance. The solution must provide bi‑directional DICOM integration with DHA Radiology PACS, body‑part and study‑name mapping, role‑based functionality, CAC‑based access, contrast‑tracking, auto‑generation of Leapfrog submission data, and a detailed topography document describing system configuration and deployment. Additional deliverables include training for 100 users across twelve PACS hubs, a project‑manager‑led kickoff within 30 days of award, monthly vulnerability/SCAP scans, and RMF certification artifacts required for ATO. Only Small Business responses will be considered; the Government has not yet determined a set‑aside status. Submissions must be a PDF (≤ 20 pages, 12‑point font, excluding cover/administrative pages) emailed to Ms. Jennifer Sikes (jennifer.m.sikes2.civ@health.mil) with the subject line “Enterprise Dose Monitoring – RFI Response.” Required content includes the capability statement, company CAGE/UEI, contact information, small‑business designation(s), NAICS code(s), and details on any existing GWAC, MAC, IDIQ, or Federal Supply Schedule contracts. Responses are voluntary, not offers, and will be used solely for market research; no contract will be awarded from this RFI.

Notice ID

540ab29ddf3446619c31f2b67457a7aa

Solicitation Number

HT9427-26-SS-JS01

NAICS Code

513210

Classification Code

7B20